secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0000917520-21-000043
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences appoints Jan De Witte as President and CEO, succeeding Peter Arduini
--------------------------------------------------------------------------------

- Jan De Witte to join prior to end of 2021; also appointed to board of directors.
- De Witte previously CEO of Barco N.V. and held senior roles at GE Healthcare IT.
- Compensation: $850k base salary, 110% target bonus, $2M initial RSU grant, severance provisions.
- Peter Arduini steps down as planned to become GE Healthcare CEO; no disagreement with Integra.
- De Witte brings 30-year healthcare/tech experience; appointment follows comprehensive CEO search.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/0000917520-21-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/iart-20211028.htm
  HTML page:      https://secwatch.observer/filing/0000917520-21-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer